registrieren | anmelden | FAQ      [?] 

Expert Opinion on Drug Safety

Articles from the last few issues of Expert Opinion on Drug Safety © Informa Healthcare
  • We are now accepting original research!
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 335-335.
    by Knowles, Elizabeth, Win, Beta
  • The root cause of patient safety concerns in an Internet pharmacy
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 337-341.
    by Montoya, D Isaac
  • The FDA Drug Safety Bill: how safe are our drugs?
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 343-346.
    by Cobert, Barton
  • Drug allergies unknown dangers to patients
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 347-350.
    by Demoly, Pascal
  • Investigations into the liver effects of ximelagatran using high content screening of primary human hepatocyte cultures
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 351-365.
    by Ainscow, K Edward, Pilling, E James, Brown, M Nick, Orme, T Alexandra, Sullivan, Michael, Hargreaves, C Andy, Cooke, Emma-Louise, Sullivan, Elaine, Carlsson, Stefan, Andersson, B Tommy
  • The cardiovascular safety of rosiglitazone
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 367-376.
    by Ajjan, A Ramzi, Grant, J Peter
  • The safety of cefepime in the treatment of infection
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 377-387.
    by Drago, Lorenzo, Vecchi, Elena De
  • Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 389-400.
    by Harris, Marianne
  • The safety of celecoxib in ankylosing spondylitis treatment
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 401-409.
    by Poddubnyy, A Denis, Song, In-Ho, Sieper, Joachim
  • Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 411-419.
    by Aringer, Martin, Smolen, S Josef
  • Activity of certain drugs in inducing of inflammatory myopathies with cutaneous manifestations
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 421-433.
    by Dourmishev, A Lyubomir, Dourmishev, L Assen
  • Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 435-445.
    by Bernardo, G Carmina, Singh, Vivek, Thompson, M Peter
  • Genotoxic effects of anesthetic agents
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 447-458.
    by Fodale, , Mondello, , Aloisi, , Schifilliti, , Santamaria, Lb
  • The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 459-472.
    by Malcolm, Robert, Olive, M Foster, Lechner, William
  • Safety of anticholinergics in patients with benign prostatic hyperplasia
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 473-479.
    by Athanasopoulos, Anastasios, Mitropoulos, Dionisios, Giannitsas, Konstantinos, Perimenis, Petros
  • Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 481-489.
    by Andres, Emmanuel, Federici, Laure, Weitten, Thierry, Vogel, Thomas, Alt, Martine
  • Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management
    Expert Opinion on Drug Safety, Vol. 7, No. 4. (July 2008), pp. 491-512.
    by Wimalawansa, J Sunil
  • Killer fentanyl: is the fear justified?
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 213-217.
    by Fodale, Vincenzo, Mafrica, Federica, Santamaria, B Letterio, Coleman, J John
  • The safety of mycophenolate mofetil in pregnancy
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 219-222.
    by Pisoni, N Cecilia, D'Cruz, P David
  • Antidepressants use in pediatric populations
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 223-225.
    by Goren, L Jessica
  • Internet healthcare: do self-diagnosis sites do more harm than good?
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 227-229.
    by Ryan, Angela, Wilson, Sue
  • Understanding drug-induced torsades de pointes: a genetic stance
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 231-239.
    by Kannankeril, J Prince
  • Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 241-258.
    by Journe, Fabrice, Body, Jean-Jacques, Leclercq, Guy, Laurent, Guy
  • Raloxifene in breast cancer prevention
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 259-270.
    by Gennari, Luigi, Merlotti, Daniela, Paola, Vincenzo De, Nuti, Ranuccio
  • Helicobacter pylori eradication therapy: indications, efficacy and safety
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 271-281.
    by Kwok, Avelyn, Lam, Thao, Katelaris, Peter, Leong, WL Rupert
  • Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 283-293.
    by Makinson, Alain, Moing, Vincent Le, Kouanfack, Charles, Laurent, Christian, Delaporte, Eric
  • Hypersensitivity reactions to cephalosporins
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 295-304.
    by Moreno, Esther, Macias, Eva, Davila, Ignacio, Laffond, Elena, Ruiz, Arturo, Lorente, Felix
  • Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant anticancer agents
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 305-318.
    by Sarapa, Nenad, Britto, R Margaret
  • Safety issues in the management of autoimmune hepatitis
    Expert Opinion on Drug Safety, Vol. 7, No. 3. (May 2008), pp. 319-333.
    by Czaja, J Albert
  • Toxicological and public good considerations for the regulation of nanomaterial-containing medical products
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 103-106.
    by Faunce, A Thomas
  • The role of early in vivo toxicity testing in drug discovery toxicology
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 107-110.
    by Fielden, R Mark, Kolaja, L Kyle
  • The safety of dopamine agonists in the treatment of Parkinson's disease
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 111-127.
    by Bonuccelli, Ubaldo, Ceravolo, Roberto
  • Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injury
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 129-146.
    by Sardo, A Vilma, Pereira, L Sandro, Oliveira, J Paulo
  • Drug-induced crystal nephropathy: an update
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 147-158.
    by Yarlagadda, G Sri, Perazella, A Mark
  • Anticancer therapy in patients with porphyrias: evidence today
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 159-165.
    by Thiery-Vuillemin, Antoine, Chaigneau, Loic, Meaux-Ruault, Nadine, Villanueva, Cristian, N'guyen, Thierry, Maurina, Tristan, Stein, Ulrich, Lorgis, Vronique, Demarchi, Martin, Pivot, Xavier
  • The safety of diclofenac for the management and treatment of actinic keratoses
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 167-172.
    by Iraji, Fariba, Siadat, Amir Hossein, Asilian, Ali, Enshaieh, Shahla, Shahmoradi, Zabiholah
  • The effect of anticholinergic agents on gastro-oesophageal reflux and related disorders
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 173-180.
    by Soest, Eva M Van, Dieleman, P Jeanne, Kuipers, J Ernst
  • Sudden cardiac death secondary to antidepressant and antipsychotic drugs
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 181-194.
    by Sicouri, Serge, Antzelevitch, Charles
  • Antiepileptic drugs as human teratogens
    Expert Opinion on Drug Safety, Vol. 7, No. 2. (March 2008), pp. 195-209.
    by Eadie, J Mervyn
  • The safety of antiretroviral drugs
    Expert Opinion on Drug Safety, Vol. 7, No. 1. (January 2008), pp. 1-4.
    by Tymchuk, N Christopher, Currier, S Judith
  • The safety of methadone hydrochloride
    Expert Opinion on Drug Safety, Vol. 7, No. 1. (January 2008), pp. 5-8.
    by Swegle, M John, Wensel, D David
  • Benefits and risks of using antidepressants in children and adolescents
    Expert Opinion on Drug Safety, Vol. 7, No. 1. (January 2008), pp. 9-27.
    by Bailly, Daniel
  • Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs
    Expert Opinion on Drug Safety, Vol. 7, No. 1. (January 2008), pp. 29-42.
    by Capone, L Marta, Tacconelli, Stefania, Francesco, Luigia Di, Petrelli, Maria, Patrignani, Paola
  • The cardiovascular safety of tadalafil
    Expert Opinion on Drug Safety, Vol. 7, No. 1. (January 2008), pp. 43-52.
    by Reffelmann, Thorsten, Kieback, Arne, Kloner, A Robert
  • Histone deacetylase inhibition in the treatment of heart disease
    Expert Opinion on Drug Safety, Vol. 7, No. 1. (January 2008), pp. 53-67.
    by Berry, M Jeff, Cao, J Dian, Rothermel, A Beverly, Hill, A Joseph
  • Effect of thiazolidinediones on skeletal health in women with Type 2 diabetes
    Expert Opinion on Drug Safety, Vol. 7, No. 1. (January 2008), pp. 69-78.
    by Schwartz, V Ann, Sellmeyer, E Deborah
  • Uses and safety profile of ciclosporin in ophthalmology
    Expert Opinion on Drug Safety, Vol. 7, No. 1. (January 2008), pp. 79-89.
    by Kashani, Shahram, Mearza, A Ali
  • Safety Pharmacology Society: 7th Annual Meeting
    Expert Opinion on Drug Safety, Vol. 7, No. 1. (January 2008), pp. 91-100.
    by Cavero, Icilio
  • Reassessing the safety of intravenous and compounded injectable colchicine in acute gout treatment
    Expert Opinion on Drug Safety, Vol. 6, No. 6. (November 2007), pp. 625-629.
    by Schlesinger, Naomi
  • The safety of amodiaquine use in pregnant women
    Expert Opinion on Drug Safety, Vol. 6, No. 6. (November 2007), pp. 631-635.
    by Tagbor, K Harry, Chandramohan, Daniel, Greenwood, Brian
    • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/journal/apl-eds

    Result page: 1 2 3 4 5 6 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.